Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |